Amylyx Pharmaceuticals (AMLX)
(Delayed Data from NSDQ)
$1.72 USD
-0.05 (-2.82%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $1.71 -0.01 (-0.58%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.38 | 0.00% |
Earnings Summary
For their last quarter, Amylyx Pharmaceuticals (AMLX) reported earnings of -$0.46 per share, missing the Zacks Consensus Estimate of $0.24 per share. This reflects a negative earnings surprise of 291.67%. Look out for AMLX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year decrease of 222.58%.
Earnings History
Price & Consensus
Zacks News for AMLX
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
AMLX: What are Zacks experts saying now?
Zacks Private Portfolio Services